Patent applications and USPTO patent grants for DEXCEL PHARMA TECHNOLOGIES LTD..The latest application filed is for "method of manufacturing an orally disintigrating tablet".
Patent | Date |
---|---|
Method Of Manufacturing An Orally Disintigrating Tablet App 20220125730 - MOSES-HELLER; Sheera ;   et al. | 2022-04-28 |
Compositions comprising dexamethasone Grant 11,304,961 - Kreyenborg , et al. April 19, 2 | 2022-04-19 |
Alternating and semi-alternating poly(ester-anhydride) copolymers Grant 11,299,583 - Domb , et al. April 12, 2 | 2022-04-12 |
Stable Benzimidazole Formulation App 20220031622 - PENHASI; Adel ;   et al. | 2022-02-03 |
Orally Disintegrating Compositions App 20210353535 - MOSES-HELLER; Sheera | 2021-11-18 |
Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic Grant 11,141,488 - Domb , et al. October 12, 2 | 2021-10-12 |
Methods for treating helicobacter infection Grant 11,096,948 - Oren August 24, 2 | 2021-08-24 |
Orally disintegrating compositions Grant 11,077,055 - Moses-Heller August 3, 2 | 2021-08-03 |
Alternating And Semi-alternating Poly(ester-anhydride) Copolymers App 20210009751 - DOMB; Abraham J. ;   et al. | 2021-01-14 |
Stable orally disintegrating pharmaceutical compositions Grant 10,835,488 - Pevzner , et al. November 17, 2 | 2020-11-17 |
Alternating and semi-alternating poly(ester-anhydride) copolymers Grant 10,774,176 - Domb , et al. Sept | 2020-09-15 |
Methods For Treating Helicobacter Infection App 20200268769 - OREN; Dan | 2020-08-27 |
Compositions comprising proton pump inhibitors Grant 10,736,855 - Gold , et al. A | 2020-08-11 |
Compositions Comprising Dexamethasone App 20200147106 - KREYENBORG; Caterina ;   et al. | 2020-05-14 |
Compositions Comprising Biodegradable Copolymers App 20200101163 - DOMB; Abraham J. ;   et al. | 2020-04-02 |
Compositions comprising dexamethasone Grant 10,537,585 - Kreyenborg , et al. Ja | 2020-01-21 |
Ophthalmic Compositions App 20190209466 - BENITA; Simon ;   et al. | 2019-07-11 |
Compositions Comprising Dexamethasone App 20190183907 - KREYENBORG; Caterina ;   et al. | 2019-06-20 |
Pharmaceutical Compositions Comprising Ferric Citrate And Methods For The Production Thereof App 20190125792 - GOLD; Tomer ;   et al. | 2019-05-02 |
Compositions Comprising Proton Pump Inhibitors For Oral Administration App 20190125676 - MOSES-HELLER; Sheera ;   et al. | 2019-05-02 |
Compositions Comprising Proton Pump Inhibitors App 20190046457 - GOLD; Tomer ;   et al. | 2019-02-14 |
Stable Orally Disintegrating Pharmaceutical Compositions App 20190008767 - PEVZNER; Victor ;   et al. | 2019-01-10 |
Pharmaceutical compositions comprising ferric citrate and methods for the production thereof Grant 10,172,882 - Gold , et al. J | 2019-01-08 |
Stable Benzimidazole Formulation App 20180271790 - PENHASI; Adel ;   et al. | 2018-09-27 |
Stable orally disintegrating pharmaceutical compositions Grant 10,076,494 - Pevzner , et al. September 18, 2 | 2018-09-18 |
Alternating And Semi-alternating Poly(ester-anhydride) Copolymers App 20180043026 - DOMB; Abraham J. ;   et al. | 2018-02-15 |
Method for treating a periodontal disease Grant 9,889,090 - Avramoff , et al. February 13, 2 | 2018-02-13 |
Stable Orally Disintegrating Pharmaceutical Compositions App 20170360697 - PEVZNER; Victor ;   et al. | 2017-12-21 |
Sustained-release donepezil formulation Grant 9,757,338 - Penhasi , et al. September 12, 2 | 2017-09-12 |
Pharmaceutical Compositions Comprising Ferric Citrate And Methods For The Production Thereof App 20170106018 - GOLD; Tomer ;   et al. | 2017-04-20 |
Orally Disintegrating Compositions App 20170042806 - MOSES-HELLER; Sheera | 2017-02-16 |
Orally Disintegrating Compositions App 20160354356 - MOSES-HELLER; Sheera | 2016-12-08 |
Method For Treating A Periodontal Disease App 20160158148 - AVRAMOFF; Avi ;   et al. | 2016-06-09 |
Method for treating a periodontal disease Grant 9,278,064 - Avramoff , et al. March 8, 2 | 2016-03-08 |
Method For Treating A Periodontal Disease App 20150024021 - Avramoff; Avi ;   et al. | 2015-01-22 |
Multiple Unit Pharmaceutical Formulation App 20140314846 - PENHASI; Adel ;   et al. | 2014-10-23 |
Method for treating a periodontal disease Grant 8,865,198 - Avramoff , et al. October 21, 2 | 2014-10-21 |
Stable Benzimidazole Formulation App 20140178469 - PENHASI; Adel ;   et al. | 2014-06-26 |
Local Therapeutic Release Device App 20120100192 - Penhasi; Adel ;   et al. | 2012-04-26 |
Method For Treating A Periodontal Disease App 20120100199 - AVRAMOFF; Avi ;   et al. | 2012-04-26 |
Specific Time-delayed Burst Profile Delivery System App 20110287094 - PENHASI; Adel ;   et al. | 2011-11-24 |
Multiple Unit Pharmaceutical Formulation App 20100297226 - Penhasi; Adel ;   et al. | 2010-11-25 |
Solid Composition for Intra-Oral Delivery of Insulin App 20090274758 - Pinhasi; Adel ;   et al. | 2009-11-05 |
Controlled Absorption Of Statins In The Intestine App 20090196889 - Penhasi; Adel | 2009-08-06 |
Controlled Absorption of Statins in the Intestine App 20080260818 - Penhasi; Adel ;   et al. | 2008-10-23 |
Specific time-delayed burst profile delivery system App 20060280795 - Penhasi; Adel ;   et al. | 2006-12-14 |
Pharmaceutical compositions containing venlafaxine App 20060057204 - Penhasi; Adel ;   et al. | 2006-03-16 |
Composition and device for treating periodontal diseases App 20040185009 - Penhasi, Adel ;   et al. | 2004-09-23 |
Delayed total release two pulse gastrointestinal drug delivery system Grant 6,632,451 - Penhasi , et al. October 14, 2 | 2003-10-14 |
Immediate release gastrointestinal drug delivery system Grant 6,531,152 - Lerner , et al. March 11, 2 | 2003-03-11 |
SEC | 0001720007 | Dexcel Pharma Technologies Ltd. of ISRAEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.